首页> 外国专利> RECOMBINANT PLASMID DNA PSS5 ENCODING SYNTHESIS OF RECOMBINANT HUMAN ALPHA-2B INTERFERON, STRAIN OF ESCHERICHIA COLI SS5 AS PRODUCER OF RECOMBINANT HUMAN ALPHA-2B INTERFERON AND METHOD OF ALPHA-2B INTERFERON PREPARING

RECOMBINANT PLASMID DNA PSS5 ENCODING SYNTHESIS OF RECOMBINANT HUMAN ALPHA-2B INTERFERON, STRAIN OF ESCHERICHIA COLI SS5 AS PRODUCER OF RECOMBINANT HUMAN ALPHA-2B INTERFERON AND METHOD OF ALPHA-2B INTERFERON PREPARING

机译:重组质粒DNA PSS5编码重组人α-2B干扰素,大肠杆菌CS5菌株作为重组人α-2B干扰素的生产者及α2b干扰素的制备方法

摘要

FIELD: biotechnology, molecular biology, genetic engineering. SUBSTANCE: cells of recipient strain E. coli BL 21 (DE3) is transformed by recombinant multicopy plasmid DNA pSS5 encoding synthesis of leukocyte human alpha-2b interferon. Expression of the latter is under control of lactose gene, phage T7 and tryptophan promoters and terminator of translation rrn B-T1T2 containing gene determining the resistance to kanamycin and containing DNA fragment from plasmid pUC19 that is responsible for replication of recombinant plasmid. Obtained strain E. coli SS5 has productivity 800 mg of alpha-2b interferon, not less, with total activity 1-2 x 1011 IU/1 l of cultural medium or 15-20 g of wet biomass of strain cells. Method involves culturing on nutrient medium, freezing cultural liquid at -70 C, not above, its defrosting by temperature increase to 4 C followed by addition of lysozyme to cultural liquid, removal of DNA and RNA by treatment of lyzate with DNase, concentration of obtained product by protein washing off with solutions of nonionic detergents, centrifugation and dissolving formed precipitate in solution of guanidine hydrochloride followed by renaturation of interferon and its purification using ion-exchange chromatography on ion-exchange resins of type Whatman CM-52-cellulose. Invention can be used for preparing recombinant human leukocyte alpha-2b interferon for medicinal aims. EFFECT: increased yield of interferon producing. 7 cl, 4 dwg, 3 ex
机译:领域:生物技术,分子生物学,基因工程。物质:通过编码白细胞人α-2b干扰素合成的重组多拷贝质粒DNA pSS5转化受体菌株大肠杆菌BL 21(DE3)的细胞。后者的表达受乳糖基因,噬菌体T7和色氨酸启动子的控制,翻译终止子包含确定卡那霉素抗性的基因BT 1 T 2 和DNA片段来自质粒pUC19,其负责重组质粒的复制。获得的菌株SS.SS5具有800 mg的α-2b干扰素产量,不少于1,其总活性为1-2 x 10 11 IU / 1 l培养基或15-20 g湿生物质应变细胞。方法包括在营养培养基上培养,将培养液冷冻至-70°C(不高于此温度),通过将温度升至4°C除霜,然后向培养液中添加溶菌酶,通过用DNase处理裂解液去除DNA和RNA,浓缩通过用非离子型去污剂溶液洗净蛋白质,离心分离和浓缩形成的沉淀,然后将其沉淀在盐酸胍溶液中,然后对干扰素进行复性,并使用离子交换色谱法在Whatman CM-52-纤维素类型的离子交换树脂上进行纯化。本发明可用于制备用于医学目的的重组人白细胞α-2b干扰素。效果:增加干扰素生产的产量。 7 cl,4 dwg,3 ex

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号